Newsletter SignupSearch

Urge Congress to Support the Creation of an FDA Neuroscience Center of Excellence

Leaders of the Congressional Neuroscience Caucus and the Brain Injury Task Force are circulating a sign-on letter to the Energy and Commerce Committee, in support of the creation of an NCOE at the FDA.

Leaders of the Congressional Neuroscience Caucus and the Brain Injury Task Force are circulating a sign-on letter to the Energy and Commerce Committee, in support of the creation of an NCOE at the FDA

The Cures 2.0 Act, recently introduced by Congresswoman Diana DeGette and Congressman Fred Upton, includes language that would pave the way for the creation of an NCOE at the FDA. This language complements the Bringing Regulatory Advances Into Neuroscience (BRAIN) Act, advanced by Congressman Earl Blumenauer, Congressman Bill Pascrell, and Congressman Don Bacon, which would direct the FDA to create an NCOE.

We call on you to urge your member of Congress to advance scientific research on brain trauma and brain health by co-sponsoring the BRAIN Act and signing the NCOE Dear Colleague letter today.

Thank you for taking action for brain health!

Send an ACTION ALERT today, it’s easy and will only take a minute!

Share this article:

More from CVB

American Brain Coalition Selects Cohen Veterans Bioscience Executive as New Board Member

New Artificial-Intelligence-based Tools for Monitoring Parkinson’s Disease using Wearable Devices

Peter Hoehn, Accomplished Pharmaceutical Executive, Joins Cohen Veterans Bioscience (CVB) in Newly Created Executive Leadership Role

About Cohen Veterans Bioscience (CVB)

Cohen Veterans Bioscience is a non-profit 501(c)(3) biomedical research and technology organization dedicated to advancing brain health by fast-tracking precision diagnostics and tailored therapeutics.